Record Full-Year Revenue Growth
Total revenue for 2025 grew 24.7% year-over-year to $646.8 million, the first substantial revenue growth since 2020 and described as a record year.
Strong ODR Performance and Mix Shift
ODR revenue increased 40.6% to $485.7 million for 2025, with organic ODR revenue growth of 17%. ODR/GCR mix improved to 75% ODR / 25% GCR for 2025 (Q4 ODR = 77.6%), up from 67% ODR / 33% GCR earlier in the year.
Record Adjusted EBITDA and Margin Expansion
Reported record full-year adjusted EBITDA of $81.8 million (up 28.4% vs. 2024) within guidance, with adjusted EBITDA margin expanding to 12.6% from 12.3%.
Strong Cash Generation and Free Cash Flow
Generated $71.9 million in cash from operations (excluding working capital) in 2025 and free cash flow of $70.1 million (up $17.8 million vs. 2024). Free cash flow conversion of adjusted EBITDA was 85.7% (vs. 82.1% prior year).
Improving Bookings and Sales Momentum
Fourth-quarter bookings were $225 million versus quarterly revenue of $187 million, indicating forward sales momentum (bookings > revenue) that provides visibility into 2026.
Balance Sheet Strength and Liquidity
As of Dec 31, 2025 cash and equivalents were $11.3 million, total debt $35.9 million, net debt of $24.6 million, net debt / adjusted EBITDA of 0.3x, and total liquidity of $96.3 million. Company authorized a $50 million share repurchase program.
Operational Wins and Strategic Initiatives
Expanded national vertical focus (healthcare, industrial manufacturing, data center), dedicated senior sales and national customer executives, emphasis on REVOLVE customer solutions, and deliberate M&A plan targeting 1–3 acquisitions in 2026.
Notable Q4 and FY Earnings Improvements
Q4 total revenue rose 30.1% to $186.9 million; Q4 adjusted EBITDA rose 30% to $27.2 million; full-year net income grew 26.5% to $39.1 million and diluted EPS rose 25.7% to $3.23.